Although the incidence of localized renal cell carcinoma has increased in recent decades due to greater use of imaging, the treatment has shifted to less invasive, nephron-sparing approaches. Radiofrequency ablation (RFA) is one accepted treatment modality for patients with small renal masses, and it has the advantage of being minimally invasive and highly nephron sparing, with the additional benefits of reduced blood loss and complication rates. We describe our experience with RFA with an accompanying instructional video outlining the procedure's key components.
Get full access to this article
View all access options for this article.
References
1.
GillIS, KavoussiLR, LaneBR, et al.Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol, 2007; 178:41–46.
2.
Van PoppelH, Da PozzoL, AlbrechtW, et al.A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol, 2011; 59:543–552.
3.
AbouassalyR, LaneBR, NovickAC. Active surveillance of renal masses in elderly patients. J Urol, 2008; 180:505–509.
4.
CampbellS, UzzoRG, AllafME, et al.Renal mass and localized renal cancer: AUA guideline. J Urol, 2017; 198:520–529.
5.
GettmanMT, LotanY, CorwinTS, et al.Radiofrequency coagulation of renal parenchyma: comparison of effects of energy generators on treatment efficacy. J Endourol, 2002; 16:83–88.
6.
NakadaSY, JerdeTJ, WarnerTF, et al.Bipolar radiofrequency ablation of the kidney: comparison with monopolar radiofrequency ablation. J Endourol, 2003; 17:927–933.
7.
ItoK, SogaS, SeguchiK, et al.Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer. Oncol Lett, 2017; 14:918–924.
8.
OganK, JacomidesL, DolmatchBL, et al.Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology, 2002; 60:954–958.
9.
GuptaA, RamanJD, LeveilleeRJ, et al.General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J Endourol, 2009; 23:1099–1105.
10.
MatsumotoED, WatumullL, JohnsonDB, et al.The radiographic evolution of radio frequency ablated renal tumors. J Urol, 2004; 172:45–48.
11.
McAchranSE, LesaniOA, ResnickMI. Radiofrequency ablation of renal tumors: past, present, and future. Urology, 2005; 66(5 Suppl):15–22.
12.
AtwellTD, SchmitGD, BoorjianSA, et al.Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol, 2013; 200:461–466.
13.
FarrellMA, CharboneauWJ, DiMarcoDS, et al.Imaging-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol, 2003; 180:1509–1513.
14.
DonatSM, DiazM, BishoffJT, et al.Follow-up for clinically localized renal neoplasms: AUA guideline. J Urol, 2013; 190:407–416.
15.
National Comprehensive Cancer Network. Kidney Cancer (Version 1.2021). 2020. www.nccn.org/professionals/physician_gls/pdf/bone.pdf (accessed August5, 2020).
16.
LumMA, ShahSB, DurackJC, NikolovskiI. Imaging of small renal masses before and after thermal ablation. Radiographics, 2019; 39:2134–2145.
17.
WhitsonJM, HarrisCR, Meng MV. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int, 2012; 110:1438–1443; discussion 1443.
WahTM, KoenigP, IrvingHC, GervaisDA, MuellerPR. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol, 2005; 16:1551–1555.
ArellanoRS, GarciaRG, GervaisDA, MuellerPR. Percutaneous CT-guided radiofrequency ablation of renal cell carcinoma: efficacy of organ displacement by injection of 5% dextrose in water into the retroperitoneum. AJR Am J Roentgenol, 2009; 193:1686–1690.
22.
RossiS, BuscariniE, GarbagnatiF, et al.Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol, 1998; 170:1015–1022.
23.
CareyRI, LeveilleeRJ. First prize: direct real-time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm. J Endourol, 2007; 21:807–813.
24.
YoungEE, CastleSM, GorbatiyV, LeveilleeRJ. Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses. J Urol, 2012; 187:1177–1182.
25.
BandiG, HedicanS, MoonT, LeeFT, NakadaSY. Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol, 2008; 22:963–967.
26.
CastleSM, GorbatiyV, AvalloneMA, EldefrawyA, CaultonDE, LeveilleeRJ. Cost comparison of nephron-sparing treatments for cT1a renal masses. Urol Oncol, 2013; 31:1327–1332.
27.
JohnsonDB, DucheneDA, TaylorGD, PearleMS, CadedduJA. Contrast-enhanced ultrasound evaluation of radiofrequency ablation of the kidney: reliable imaging of the thermolesion. J Endourol, 2005; 19:248–252.
28.
GuoF, HuB, ChenL, LiJ. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation. Br J Radiol, 2019; 92:20190183.
29.
GervaisDA, McGovernFJ, ArellanoRS, McDougalWS, MuellerPR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol, 2005; 185:64–71.
30.
BestSL, ParkSK, YoussefRF, et al.Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J Urol, 2012; 187:1183–1189.
31.
PierorazioPM, JohnsonMH, PatelHD, et al.Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol, 2016; 196:989–999.
32.
ThompsonRH, AtwellT, SchmitG, et al.Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol, 2015; 67:252–259.
33.
ChangX, LiuT, ZhangF, et al.Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol, 2015; 29:518–525.
34.
TracyCR, RamanJD, DonnallyC, TrimmerCK, CadedduJA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer, 2010; 116:3135–3142.
35.
OlwenyEO, ParkSK, TanYK, BestSL, TrimmerC, CadedduJA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol, 2012; 61:1156–1161.
RamirezD, MaY-B, BedirS, AntonelliJA, CadedduJA, GahanJC. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. J Endourol, 2014; 28:330–334.
38.
MaY, BedirS, CadedduJA, GahanJC. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int, 2014; 113:51–55.
39.
LorberG, GlamoreM, DoshiM, JordaM, Morillo-BurgosG, LeveilleeRJ. Long-term oncologic outcomes following radiofrequency ablation with real-time temperature monitoring for T1a renal cell cancer. Urol Oncol, 2014; 32:1017–1023.
40.
ChoueiriTK, SchutzFAB, HeveloneND, et al.Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Urology, 2011; 78:93–98.
41.
AtwellTD, CarterRE, SchmitGD, et al.Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J Vasc Interv Radiol, 2012; 23:48–54.
42.
TanaghoYS, RoytmanTM, BhayaniSB, et al.Laparoscopic cryoablation of renal masses: single-center long-term experience. Urology, 2012; 80:307–314.
43.
JohnsonBA, SorokinI, CadedduJA. Ten-year outcomes of renal tumor radio frequency ablation. J Urol, 2019; 201:251–258.
